banner-risc-cardiovascular

Publicaciones

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

O. GAUFFIN, J. BRAND, S. VIDLIN, D. SARTORI, S. ASIKAINEN, M. CATALÀ, E. CHALABI, D. DEDMAN, A. DANILOVIC, T. DUARTE-SALLES, M. MORALES, S. HILTUNEN, A. JÖDICKE, M. LAZAREVIC, M. MAYER, J. MILADINOVIC, J. MITCHELL, A. PISTILLO, J. RAMÍREZ-ANGUITA, C. REYES, A. RUDOLPH, L. SANDBERG, R. SAVAGE, M. SCHUEMIE, D. SPASIC, N. TRINH, N. VELJKOVIC, A. VUJOVIC, M. DE WILDE, A. ZEKARIAS, P. RIJNBEEK, P. RYAN, D. PRIETO-ALHAMBRA and G. NORÉN
DRUG SAFETY. 2023 Oct 7; . doi:10.1007/s40264-023-01353-w; PMID:37804398

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.

Khera R, Dhingra LS, Aminorroaya A, Li K, Zhou JJ, Arshad F, Blacketer C, Bowring MG, Bu F, Cook M, Dorr DA, Duarte-Salles T, DuVall SL, Falconer T, French TE, Hanchrow EE, Horban S, Lau WC, Li J, Liu Y, Lu Y, Man KK, Matheny ME, Mathioudakis N, McLemore MF, Minty E, Morales DR, Nagy P, Nishimura A, Ostropolets A, Pistillo A, Posada JD, Pratt N, Reyes C, Ross JS, Seager S, Shah N, Simon K, Wan EY, Yang J, Yin C, You SC, Schuemie MJ, Ryan PB, Hripcsak G, Krumholz H and Suchard MA
Bmj Medicine. 2023 Oct 6; . doi:10.1136/bmjmed-2023-000651; PMID:37829182

Trends in the prescription of anti-dementia treatments in Spain and the UK: A large network population-based cohort study

C. REYES, D. NEWBY, E. BURN, B. RAVENTÓS and T. DUARTE-SALLES
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Body mass index and incident cardiometabolic conditions in relation to obesity-related cancer risk: A population-based cohort study in Catalonia, Spain

M. RECALDE, A. PISTILLO, V. VIALLON, E. FONTVIEILLE, T. DUARTE-SALLES and H. FREISLING
Cancer Medicine. 2023 Oct 1; . doi:10.1002/cam4.6603; PMID:37766588

Agreement of COVID-19 incidence between the authoritative data and real-world evidence in England

X. LI, B. RAVENTÓS, Y. GUO, M. DU, E. BURN, D. PRIETO-ALHAMBRA and M. SABATÉ
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Effect of COVID-19 vaccination on thromboembolic and cardiovascular complications following SARS-CoV-2 infection

N. BESORA, A. JÖDICKE, E. ROEL, A. DELMESTRI, C. PRATS, D. PRIETO-ALHAMBRA and M. SABATÉ
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Establishing and characterizing large COVID-19 cohorts after mapping the information system for research in primary care (SIDIAP) in Catalonia to the OMOP common data model

B. RAVENTOS, S. FERNÁNDEZ-BERTOLÍN, J. WEAVER, C. BLACKETER, M. ARAGÓN, M. RECALDE, E. ROEL, A. PISTILLO, C. REYES, S. VAN SANDIJK, L. HALVORSEN, P. RIJNBEEK, E. BURN and T. DUARTE-SALLES
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Long COVID symptoms following primo- versus reinfection: A multinational cohort analysis of primary care records from Catalonia and the UK

K. KOSTKA, E. ROEL, N. TRINH, A. DELMESTRI, L. MATEAU, R. PAREDES, T. DUARTE-SALLES, D. PRIETO-ALHAMBRA, M. SABATÉ and A. JÖDICKE
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Effect of COVID-19 vaccines on post-COVID cardiac and thromboembolic complications

N. BESORA, D. PRIETO-ALHAMBRA, E. ROEL, A. DELMESTRI, C. PRATS, A. JÖDICKE and M. SABATÉ
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Changes in air pollution exposure after residential relocation and body mass index in children and adolescents: A natural experiment study?

S. WARKENTIN, J. DE BONT, A. ABELLAN, A. PISTILLO, A. SAUCY, M. CIRACH, M. NIEUWENHUIJSEN, S. KHALID, X. BASAGAÑA, T. DUARTE-SALLES and M. VRIJHEID
ENVIRONMENTAL POLLUTION. 2023 Oct 1; . doi:10.1016/j.envpol.2023.122217; PMID:37467916